Proto Labs Balance Sheet Health
Financial Health criteria checks 6/6
Proto Labs has a total shareholder equity of $680.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $753.8M and $73.8M respectively. Proto Labs's EBIT is $29.8M making its interest coverage ratio -13.6. It has cash and short-term investments of $100.5M.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | -13.6x |
Cash | US$100.51m |
Equity | US$679.99m |
Total liabilities | US$73.79m |
Total assets | US$753.79m |
Recent financial health updates
No updates
Recent updates
Is Now An Opportune Moment To Examine Proto Labs, Inc. (NYSE:PRLB)?
Dec 22Proto Labs' (NYSE:PRLB) Performance Is Even Better Than Its Earnings Suggest
Nov 14Proto Labs, Inc.'s (NYSE:PRLB) 36% Jump Shows Its Popularity With Investors
Nov 02Here's What's Concerning About Proto Labs' (NYSE:PRLB) Returns On Capital
Sep 08Proto Labs: Defensive Strategy Not Paying Off Yet
Aug 13Calculating The Intrinsic Value Of Proto Labs, Inc. (NYSE:PRLB)
Jul 18Proto Labs: Interesting Crossroads
May 28Proto Labs' (NYSE:PRLB) Solid Earnings Are Supported By Other Strong Factors
May 11Proto Labs, Inc.'s (NYSE:PRLB) Price In Tune With Revenues
Apr 13Proto Labs: Cash Flows Are Supporting The Stock
Mar 04Proto Labs: Excellent Business Feats Yet To Financially Materialize
Feb 16Proto Labs (NYSE:PRLB) May Have Issues Allocating Its Capital
Jan 03Proto Labs: Overlooked Digital Manufacturing Opportunity
Dec 04Proto Labs Remains Profitable Despite So Much Pessimism
Sep 25Proto Labs: The Rally Appears Overdone
Jul 14Be Wary Of Proto Labs (NYSE:PRLB) And Its Returns On Capital
Jul 13Is There An Opportunity With Proto Labs, Inc.'s (NYSE:PRLB) 41% Undervaluation?
May 06Proto Labs (NYSE:PRLB) Might Be Having Difficulty Using Its Capital Effectively
Apr 08Proto Labs Non-GAAP EPS of $0.26 beats by $0.05, revenue of $115.6M beats by $5.47M
Feb 10Proto Labs: Transitioning From A Fast Grower To A Slow Grower
Jan 20Some Investors May Be Worried About Proto Labs' (NYSE:PRLB) Returns On Capital
Dec 21Proto Labs Q3 2022 Earnings Preview
Nov 03Proto Labs: Improvement Of The Digital Model And Undervalued
Oct 27Is It Too Late To Consider Buying Proto Labs, Inc. (NYSE:PRLB)?
Sep 12Protolabs names new technology chief
Sep 08Some Investors May Be Worried About Proto Labs' (NYSE:PRLB) Returns On Capital
Aug 05Proto Labs Q2 2022 Earnings Preview
Aug 04Proto Labs: Not A Great Prospect Until Profitability Issues Clear Up
Jul 07Is Proto Labs, Inc. (NYSE:PRLB) Potentially Undervalued?
May 24Proto Labs (NYSE:PRLB) Could Be Struggling To Allocate Capital
Mar 30The Prognosis For Proto Labs
Feb 22Returns On Capital At Proto Labs (NYSE:PRLB) Paint A Concerning Picture
Nov 28Is There Now An Opportunity In Proto Labs, Inc. (NYSE:PRLB)?
Nov 10Proto Labs: A Play On Additive Manufacturing
Nov 04Investors Could Be Concerned With Proto Labs' (NYSE:PRLB) Returns On Capital
Aug 29Some Investors May Be Willing To Look Past Proto Labs' (NYSE:PRLB) Soft Earnings
Aug 14Financial Position Analysis
Short Term Liabilities: PRLB's short term assets ($193.1M) exceed its short term liabilities ($53.8M).
Long Term Liabilities: PRLB's short term assets ($193.1M) exceed its long term liabilities ($20.0M).
Debt to Equity History and Analysis
Debt Level: PRLB is debt free.
Reducing Debt: PRLB had no debt 5 years ago.
Debt Coverage: PRLB has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: PRLB has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 13:07 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Proto Labs, Inc. is covered by 15 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Robert Wasserman | Benchmark Company |
Andrew DeGasperi | Berenberg |
Robert Burleson | Canaccord Genuity |